Landsberg Bennett & Dubbaneh’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Landsberg Bennett & Dubbaneh's PFE Position: Q3 2021 in Review
Landsberg Bennett & Dubbaneh reduced its Pfizer (PFE) stake by 16% in Q3 2021, selling an estimated $48.1K and leaving 5,564 shares worth $239K. The position accounts for 0.03% of the portfolio, ranked #251.
Landsberg Bennett & Dubbaneh first reported a position in PFE in Q4 2018 and has held it in 12 quarters since. The position peaked at $3.8M in Q2 2019. 2,804 funds tracked by Wall St. Rank hold PFE as of Q3 2021.
- Landsberg Bennett & Dubbaneh held 5,564 shares of Pfizer worth $239K as of Q3 2021.
- Landsberg Bennett & Dubbaneh sold 1,086 Pfizer shares in Q3 2021, an estimated $48.1K.
- Pfizer made up 0.03% of Landsberg Bennett & Dubbaneh's portfolio in Q3 2021, its #251 holding.
- Landsberg Bennett & Dubbaneh first reported a position in Pfizer in Q4 2018 and has held it in 12 quarters since.
- Landsberg Bennett & Dubbaneh's Pfizer position peaked at $3.8M in Q2 2019.
- 2,804 funds tracked by Wall St. Rank held Pfizer as of Q3 2021.
Based on Landsberg Bennett & Dubbaneh's 13F filing for Q3 2021, filed 29 Oct 2021.